Brief report: Lack of response in an autistic population to a low dose clinical trial of pyridoxine plus magnesium

@article{Tolbert1993BriefRL,
  title={Brief report: Lack of response in an autistic population to a low dose clinical trial of pyridoxine plus magnesium},
  author={L. Tolbert and T. Haigler and M. Waits and T. Dennis},
  journal={Journal of Autism and Developmental Disorders},
  year={1993},
  volume={23},
  pages={193-199}
}
  • L. Tolbert, T. Haigler, +1 author T. Dennis
  • Published 1993
  • Medicine
  • Journal of Autism and Developmental Disorders
  • The initial studies of the efficacy of megavitamin therapy in general, and pyridoxine in particular, in an autistic population were conducted by Rimland (1973; Rimland, Caltaway, & Dreyfuss, 1978). Subsequent to Rimland's positive reports, a group of investigators in France evaluated pyridoxine or pyridoxine plus magnesium interventions in autistic subjects in a series of reports employing both open and double-blind trials with both "clinical impression" and objectively scored behavioral… CONTINUE READING

    Topics from this paper.

    Novel treatments for autistic spectrum disorders.
    • 170
    • Open Access
    The screening and diagnosis of autistic spectrum disorders.
    • 546
    • Open Access
    The status of pharmacotherapy for autism spectrum disorders
    • 64
    • Highly Influenced

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 17 REFERENCES
    Vitamin B6 Safety Issues
    • 46
    Safety of pyridoxine--a review of human and animal studies.
    • 58
    • Open Access
    A scale for rating symptoms of patients with the syndrome of autism in real life settings.
    • 132
    Carpal tunnel syndrome and vitamin B6.
    • 35